The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy
出版年份 2019 全文链接
标题
The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy
作者
关键词
-
出版物
Expert Opinion on Drug Discovery
Volume -, Issue -, Pages 1-16
出版商
Informa UK Limited
发表日期
2019-05-09
DOI
10.1080/17460441.2019.1613370
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma
- (2018) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- Reciprocal loop of hypoxia-inducible factor-1α (HIF-1α) and metastasis-associated protein 2 (MTA2) contributes to the progression of pancreatic carcinoma by suppressing E-cadherin transcription
- (2018) Shuai Zhu et al. JOURNAL OF PATHOLOGY
- LBH589 Inhibits Glioblastoma Growth and Angiogenesis Through Suppression of HIF-1α Expression
- (2017) Zhi-Gang Yao et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Inhibition of the H3K9 methyltransferase G9A attenuates oncogenicity and activates the hypoxia signaling pathway
- (2017) Jolene Caifeng Ho et al. PLoS One
- The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth
- (2017) Hyun Seung Ban et al. Cell Death & Disease
- Panobinostat: A histone deacetylase inhibitor for the treatment of relapsed or refractory multiple myeloma
- (2016) K. Wahaib et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Identification of Targets of the HIF-1 Inhibitor IDF-11774 Using Alkyne-Conjugated Photoaffinity Probes
- (2016) Hyun Seung Ban et al. BIOCONJUGATE CHEMISTRY
- Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma
- (2016) S. E. Assouline et al. BLOOD
- Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle-Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer
- (2016) E. Pham et al. CANCER RESEARCH
- A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
- (2016) Eli M. Wallace et al. CANCER RESEARCH
- HIF-2α phosphorylation by CK1δ promotes erythropoietin secretion in liver cancer cells under hypoxia
- (2016) Evanthia Pangou et al. JOURNAL OF CELL SCIENCE
- Cardenolides from Calotropis gigantea as potent inhibitors of hypoxia-inducible factor-1 transcriptional activity
- (2016) Supawadee Parhira et al. JOURNAL OF ETHNOPHARMACOLOGY
- Targeting renal cell carcinoma with a HIF-2 antagonist
- (2016) Wenfang Chen et al. NATURE
- On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
- (2016) Hyejin Cho et al. NATURE
- A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors
- (2016) Ning Jin et al. ONCOLOGIST
- CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing
- (2016) Andrew J. Clark et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protein kinase A–dependent phosphorylation stimulates the transcriptional activity of hypoxia-inducible factor 1
- (2016) John W. Bullen et al. Science Signaling
- Protein kinase A–dependent phosphorylation stimulates the transcriptional activity of hypoxia-inducible factor 1
- (2016) John W. Bullen et al. Science Signaling
- PI3K–mTORC2 but not PI3K–mTORC1 Regulates Transcription of HIF2A/EPAS1 and Vascularization in Neuroblastoma
- (2015) Sofie Mohlin et al. CANCER RESEARCH
- CK1δ restrains lipin-1 induction, lipid droplet formation and cell proliferation under hypoxia by reducing HIF-1α/ARNT complex formation
- (2015) Maria Kourti et al. CELLULAR SIGNALLING
- Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RAR and PLZF-RAR -Driven Leukemia
- (2015) N. Coltella et al. CLINICAL CANCER RESEARCH
- HIF3α: the little we know
- (2015) Linda Ravenna et al. FEBS Journal
- The Histone Methyltransferase Inhibitor BIX01294 Inhibits HIF-1α Stability and Angiogenesis
- (2015) Su Young Oh et al. MOLECULES AND CELLS
- Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma
- (2015) E. Q. Lee et al. NEURO-ONCOLOGY
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- Indole-3-ethylsulfamoylphenylacrylamides: Potent histone deacetylase inhibitors with anti-inflammatory activity
- (2014) Samir Mehndiratta et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A Group of Novel HIF-1α Inhibitors, Glyceollins, Blocks HIF-1α Synthesis and Decreases Its Stability via Inhibition of the PI3K/AKT/mTOR Pathway and Hsp90 Binding
- (2014) Sun-Hee Lee et al. JOURNAL OF CELLULAR PHYSIOLOGY
- NNC 55-0396, a T-type Ca2+ channel inhibitor, inhibits angiogenesis via suppression of hypoxia-inducible factor-1α signal transduction
- (2014) Ki Hyun Kim et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The Histone Deacetylase Inhibitor, Vorinostat, Represses Hypoxia Inducible Factor 1 Alpha Expression through Translational Inhibition
- (2014) Darren M. Hutt et al. PLoS One
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growth
- (2013) Noel A Warfel et al. CELL CYCLE
- First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies
- (2013) Glen J. Weiss et al. INVESTIGATIONAL NEW DRUGS
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells
- (2013) M R Pawlus et al. ONCOGENE
- Molecular, functional, and gene expression analysis of zebrafish hypoxia-inducible factor-3α
- (2012) Peng Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- From stem cells to cancer stem cells: HIF takes the stage
- (2012) Kyoung Eun Lee et al. CURRENT OPINION IN CELL BIOLOGY
- Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors
- (2012) Yan Xia et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The Acetylase/Deacetylase Couple CREB-binding Protein/Sirtuin 1 Controls Hypoxia-inducible Factor 2 Signaling
- (2012) Rui Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HIF1α Protein Stability Is Increased by Acetylation at Lysine 709
- (2012) Hao Geng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib
- (2012) Anja Lachenmayer et al. JOURNAL OF HEPATOLOGY
- Synthesis and Structure–Activity Relationship of (E)-Phenoxyacrylic Amide Derivatives as Hypoxia-Inducible Factor (HIF) 1α Inhibitors
- (2012) Ravi Naik et al. JOURNAL OF MEDICINAL CHEMISTRY
- Upstream Stimulatory Factor 2 and Hypoxia-Inducible Factor 2 (HIF2 ) Cooperatively Activate HIF2 Target Genes during Hypoxia
- (2012) M. R. Pawlus et al. MOLECULAR AND CELLULAR BIOLOGY
- Glyceollins, a novel class of soy phytoalexins, inhibit angiogenesis by blocking the VEGF and bFGF signaling pathways
- (2012) Sun H. Lee et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
- (2012) Nanduri R. Prabhakar et al. PHYSIOLOGICAL REVIEWS
- Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects
- (2011) Puja Sapra et al. ANGIOGENESIS
- Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites
- (2011) Melissa B. Pappalardi et al. BIOCHEMICAL JOURNAL
- Inhibitory effect of glyceollin isolated from soybean against melanogenesis in B16 melanoma cells
- (2011) Young-Sang Lee et al. BMB Reports
- The Hypoxia-Associated Factor Switches Cells from HIF-1 - to HIF-2 -Dependent Signaling Promoting Stem Cell Characteristics, Aggressive Tumor Growth and Invasion
- (2011) M. Y. Koh et al. CANCER RESEARCH
- H3K9 methyltransferase G9a and the related molecule GLP
- (2011) Y. Shinkai et al. GENES & DEVELOPMENT
- HDAC4 Protein Regulates HIF1α Protein Lysine Acetylation and Cancer Cell Response to Hypoxia
- (2011) Hao Geng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosis
- (2011) Federico A Monzon et al. MODERN PATHOLOGY
- Preclinical study of the cyclodextrin-polymer conjugate of camptothecin CRLX101 for the treatment of gastric cancer
- (2011) Shikha Gaur et al. Nanomedicine-Nanotechnology Biology and Medicine
- LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1α via upregulation of VHL in a colon cancer cell line
- (2010) Kyeong Lee et al. BIOCHEMICAL PHARMACOLOGY
- Hypoxia-inducible factor (HIF)-3α is subject to extensive alternative splicing in human tissues and cancer cells and is regulated by HIF-1 but not HIF-2
- (2010) Annika Pasanen et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Glyceollins, One of the Phytoalexins Derived from Soybeans under Fungal Stress, Enhance Insulin Sensitivity and Exert Insulinotropic Actions
- (2010) Sunmin Park et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Plk3 Functions as an Essential Component of the Hypoxia Regulatory Pathway by Direct Phosphorylation of HIF-1α
- (2010) Dazhong Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Casein kinase 1 regulates human hypoxia-inducible factor HIF-1
- (2010) A. Kalousi et al. JOURNAL OF CELL SCIENCE
- mTORC1 Signaling under Hypoxic Conditions Is Controlled by ATM-Dependent Phosphorylation of HIF-1α
- (2010) Hakan Cam et al. MOLECULAR CELL
- Sirtuin 1 Modulates Cellular Responses to Hypoxia by Deacetylating Hypoxia-Inducible Factor 1α
- (2010) Ji-Hong Lim et al. MOLECULAR CELL
- Effects of glyceollin I on vascular contraction in rat aorta
- (2010) Min-Ji Song et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Hypoxia-Inducible Factor-3α Functions as an Accelerator of 3T3-L1 Adipose Differentiation
- (2009) Misaki Hatanaka et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Hsp70 and CHIP Selectively Mediate Ubiquitination and Degradation of Hypoxia-inducible Factor (HIF)-1α but Not HIF-2α
- (2009) Weibo Luo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypoxia/Reoxygenation-Induced Mutations in Mammalian Cells Detected by the Flow Cytometry Mutation Assay and Characterized by Mutant Spectrum
- (2009) Stephen B. Keysar et al. RADIATION RESEARCH
- Regulation of Hypoxia-Inducible Factor 2 Signaling by the Stress-Responsive Deacetylase Sirtuin 1
- (2009) E. M. Dioum et al. SCIENCE
- Novel Prodrugs of SN38 Using Multiarm Poly(ethylene glycol) Linkers
- (2008) Hong Zhao et al. BIOCONJUGATE CHEMISTRY
- Novel Delivery of SN38 Markedly Inhibits Tumor Growth in Xenografts, Including a Camptothecin-11-Refractory Model
- (2008) P. Sapra et al. CLINICAL CANCER RESEARCH
- Differential Dependence of Hypoxia-inducible Factors 1α and 2α on mTORC1 and mTORC2
- (2008) Alfredo Toschi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypoxia-Associated Factor, a Novel E3-Ubiquitin Ligase, Binds and Ubiquitinates Hypoxia-Inducible Factor 1 , Leading to Its Oxygen-Independent Degradation
- (2008) M. Y. Koh et al. MOLECULAR AND CELLULAR BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started